z-logo
Premium
A New Homozygous IGF1R Variant Defines a Clinically Recognizable Incomplete Dominant form of SHORT Syndrome
Author(s) -
Prontera Paolo,
Micale Lucia,
Verrotti Alberto,
Napolioni Valerio,
Stangoni Gabriela,
Merla Giuseppe
Publication year - 2015
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/humu.22853
Subject(s) - insulin like growth factor 1 receptor , biology , missense mutation , proband , phenotype , genetics , exome sequencing , mutation , genetic heterogeneity , dwarfism , pi3k/akt/mtor pathway , exome , short stature , gene , endocrinology , receptor , signal transduction , growth factor
Here, we describe a child, born from consanguineous parents, with clinical features of SHORT syndrome, high IGF1 levels, developmental delay, CNS defects, and marked progeroid appearance. By exome sequencing, we identified a new homozygous c.2201G>T missense mutation in the IGF1R gene. Proband's parents and other relatives, all heterozygous carriers of the mutation, presented with milder phenotype including high IGFI levels, short stature, and type 2 diabetes. Functional studies using patient's cell lines showed a lower IGF1R expression that leads to the alteration of IGF1R‐mediated PI3K/AKT/mTOR downstream pathways, including autophagy. This study defines a clinically recognizable incomplete dominant form of SHORT syndrome, and provides relevant insights into the pathophysiological and phenotypical consequences of IGF1R mutations.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here